Fluconazol: Comparison of pharmacokinetics, therapy and in vitro susceptibility of yeasts;Fluconazol: Vergleich von Pharmakokinetik, Therapie und Empfindlichkeit der Sproßpilze in vitro

Mycoses, Supplement

Volumn 39, Issue 2, 1996, Pages 51-57

  Wildfeuer, A ^a   Laufen, H ^a,b   Schmalreck, A F ^b   Yeates, R A ^a,b   Zimmermann, T ^a,b  

^a Mikrobiologie Forschung Und Entwicklung   (Germany)

^b Heinrich Mack Nachf   (Germany)

Author keywords

Fluconazole; Minimal inhibitory concentrations; Pharmacokinetics; Yeasts

Indexed keywords

FLUCONAZOLE;

CONFERENCE PAPER; DRUG SCREENING; DRUG SENSITIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; YEAST;

ANTIFUNGAL AGENTS; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; TISSUE DISTRIBUTION; YEASTS;

EID: 0030425187     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Humphrey, M. J , Jevons, S. & Tarbit, M. H. (1985) Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother. 28, 648-653.
2. Grant, S. M. & Clissold, S. P. (1990) Fluconazole. A review of pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39, 877-916.
3. Yeates, R. A , Zimmermann, T , Laufen, H et al. (1995) Comparative pharmacokinetics of fluconazole and of itraconazole in Japanese and in German subjects. Int. J. Clin. Pharm. Therap. 32, 131-135.
4. Brammer, K. W., Farrow, P. R. & Faulkner, J. K. (1990) Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12, Suppl. 3, 318-326.
5. Anaissie, E., Kontoyiannas, D., Huls, C. et al. (1992) Efficacy, safety and pharmacokinetics of high dose fluconazole in patients with fungal infections. Abstr. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, California.
6. Wildfeuer, A., Pfaff, G., Zimmermann T. et al. (1991) Pharmakokinetisches Profil von Fluconazol, einem systemischen Antimykotikum. Med. Welt 42, 436-440.
7. Rieder-Nelissen, C. M., Hasse &, Yeates, R. A. (1996) Wirkstoff-konzentrationen von Fluconazol in Lungengewebe und Perikardflüssigkeit. Abstr 30. Wiss. Tagung d. Deutschsprachigen Mykologischen Gesellschaft, Kiel.
8. Byers, M., Chapman, S., Feldman S. et al. (1992) Fluconazole pharmacokinetics in the cerebrospinal fluid of a child with Candida tropicalis meningitis. Pediatr. Infect. Dis. J. 11, 895-896.
9. Tucker, R. M., Williams, P. L., Arathoon, E. G. et al (1988) Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob. Agents Chemother. 32, 369-373.
10. Chin, T., Fong I. W. & Vandenbroucke, A. (1990) Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. Pharmacotherapy 10, 305-307.
11. Thaler, F., Bernard, B , Tod, M. et al. (1995) Fluconazole penetration in cerebral parenchyma in humans at steady state. Antimicrob. Agents Chemother. 39, 1154-1156.
12. Aust, R., Kruse, A., Wildfeuer, A. et al. (1995) Kammerwasserspiegel von Fluconazol nach oaler Gabe des Wirkstoffes beim Menschen. Ophthalmologie 92, 829-832.
13. Ebden, P., Neill, P. & Farrow P.R. (1989) Sputum levels of fluconazole in humans. Antimicrob. Agents Chemother. 33, 963-961.
14. Laufen, H., Yeates, R.A., Zimmermann, T. et al. (1995) Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension. Drugs Exptl. Clin. Res XXI, 23-28.
15. Mikamo, H., Kawazoe, K., Izumi K. et al. (1995) Pharmacokinetics of fluconazole in the serum and exudate of the pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy. Clin. Drug Invest. 10, 104-109.
16. O'Meeghan, T., Varcoe, R., Thomas, M. & Ellis-Pegler, R. (1990) Fluconazole concentration in joint fluid during successful treatment of Candida albicans septic arthritis. J. Antimicrob. Chemother. 26, 601-602.
17. Kostiuk, K. A., Pons, V. G., Guglielmo B. J. et al. (1994) Penetration of fluconazole into abscess fluid. J. Antimicrob. Chemother 34, 603-605.
18. Haneke E. (1992) Pharmacokinetic evaluation of fluconazole in plasma, epidermis and blister fluid. Int. J. Dermatol. 31, Suppl. 2, 3-5.
19. Houang, E. T., Chappatte, O , Byrne, D. et al (1990) Fluconazole levels in plasma and vaginal secretions of patients after a 150 milligram single oral dose and rate of eradication of infection in vaginal candidiasis. Antimicrob. Agents Chemother. 34, 909-910.
20. Dellenbach, P. (1989) Penetration of fluconazole into vaginal tissues and secretions. Royal Society of Medicin. Symposium 160, 19-22.
21. Mikamo, H., Kawazoe, K., Izumi, K. et al. (1995) Penetration of fluconazole into gynaecological tissues. Clin. Drug Invest. 10, 48-52.
22. Schramm, P., Wildfeuer, A. & Sarnow, E. (1991) Determination of fluconazole concentrations in the prostatic and seminal vesicle fluid (split ejaculate), mycoses 37, 417-120.
23. Milliken, S., Powles, R , Jones, A. et al. (1989) Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan. Transplant Proc. 21, 3067.
24. Rubin, R., Robinson, P. A., Knirsch, A. K. et al. (1989) Fluconazole therapy of patients with AIDS and cryptococcal meningitis and failed conventional antifungal therapy. Abstr. 5th International Conference AIDS, Montreal, Canada.
25. Powderly, W. G., Saag, M. S., Cloud, G. A. et al. (1992) A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl. J. Med. 326, 793-798.
26. Haubrich, R. H., Haghighat, D., Bozzette, S. A., Tilles, J , & McCutchan, J. A. (1994) High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J. Infect. Dis 170, 238-242.
27. Menichetti, F., Fiorio, M., Tosti, A. et al. (1996) High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 22, 838-810.
28. Ikemoto H. A (1989) A clinical study of fluconazole for the treatment of deep mycoses. Diagn. Microbiol. Infect Dis. 12, Suppl. 4, 239-247.
29. Viviani, M. A., Tortorano, A M , Carraro P.S. et al. (1989) Thérapie au fluconazole de la candidose profonde chez les malades soumis à traitemont chirurgical. Bulletin de la Société Francaise de Mycologie Médicale 18, 65-68.
30. Rex, J. H , Bennett, J. E , Sugar, A. M. et al (1994) A randomised trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331, 1329-1330.
31. De Wit, S , Goosens, H. & Clumeck, X. (1989) Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1, 746-747.
32. Just-Nubling, G., Gentschew, G., Dohle, M. et al (1990) Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients. Mycoses 33, 435-440.
33. Ruhnke, M., Eigler, A , Engelmann, E. et al. (1991) Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection 22, 72-76.
34. Graybill, I. R., Vazquez, J. Daromshe, R. O et al (1995) Itraconazole oral solution (IS) versus fluconazole (F) treatment of oropharyngeal candidiasis (OC). Abstr. 35th ICAAC, 244.
35. Gil, A., Lavilla, P., Gonzales, A. et al. (1989) Fluconazole treatment of esophageal candidiasis in AIDS patients. Abstr. 5th International Conference AIDS, Montreal, Candada.
36. Laine, L., Dretler, R. H , Conteas, C. N. et al. (1992) Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS . A randomized trial. Ann Intern Med. 117, 655-660.
37. De los Reyes, C., Edelman, D. E. & De Bruin, M. F. (1992) Clinical experience with single-dose fluconazole in vaginal candidiasis. A review of the worldwide database. Int. J. Gynecol. Obstet. 37 (Suppl.), 9-15.
38. Voss, A., Meis, J. F. G. M. & Hoogkamp-Korstanje, J A. A (1994) Fluconazole in the management of fungal urinary tract infections. Infection 22, 247-251.
39. Soto, M. E. R., (1990) Estudie clinica on fluconazol oral de 150 mgrs en el tratamiento de pacientes con tina corporal/crural y tina de los pies. Revista Medica de Costa Rica, LVII (512), 101-106.
40. Del Aquila, R., Montero Gei, F. Robles, M., Perera-Ramirez, A. & Male, O. (1992) Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. Clin. Exper Dermatol. 17, 402-406.
41. Schmalreck, A. F. et al. (1996) Empfindlichkeitsprufung von Fluconazol: Auswertung einer Multicenter-Studie der Arbeitsgemeinschaft "Klinische Mykologie" der Deutschsprachigen Mykologischen Gesellschaft. mycoses 39, Suppl. 2, 1-11.
42. Schmalreck, A.-F. und Fegeler, W. (1996) Kriterien zur Empfindlichkeitsprufung von Hefen gegenüber Fluconazol im Mikrodilutionstest: Vorschlag für eine standardisierte Methode zur Testung von Sproßpilzen. mycoses, 39, Suppl. 2. 12-16.